Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Sarcopenia | Research

Possible sarcopenia and risk of new-onset type 2 diabetes mellitus in older adults in China: a 7-year longitudinal cohort study

Authors: Chun Luo, Rui-yan Liu, Guang-wu Zhang, Fei Hu, Yu-hong Jin, Bing-yang Liu

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Previous studies have shown that type 2 diabetes mellitus (T2DM) can cause sarcopenia; however, these conditions may have a bidirectional association. This study aimed to explore the longitudinal association between possible sarcopenia and new-onset T2DM.

Methods

We conducted a population-based cohort study using nationally representative data from the China Health and Retirement Longitudinal Study (CHARLS). This study included participants aged ≥ 60 years who were free of diabetes during the baseline survey of CHARLS (2011 to 2012) and were followed up until 2018. Possible sarcopenia status was defined according to the Asian Working Group for Sarcopenia 2019 criteria. Cox proportional hazards regression models were used to evaluate the effect of possible sarcopenia on new-onset T2DM.

Results

In total, 3,707 individuals were enrolled in this study, with a median age of 66 years; the prevalence of possible sarcopenia was 45.1%. During the 7-year follow-up, 575 cases (15.5%) of incident diabetes were identified. Participants with possible sarcopenia were more likely to have new-onset T2DM than those without possible sarcopenia (hazard ratio: 1.27, 95% confidence interval: 1.07–1.50; p = 0.006). In subgroup analysis, we found a significant association between possible sarcopenia and T2DM in individuals aged < 75 years or with a BMI < 24 kg/m². However, this association was not significant in individuals aged ≥ 75 years or with a BMI ≥ 24 kg/m².

Conclusions

Possible sarcopenia is associated with an increased risk of new-onset T2DM in older adults, especially in individuals who are not overweight and aged 75 years or younger.
Appendix
Available only for authorised users
Literature
1.
go back to reference ElSayed NA et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care[J], 2023. 46(Suppl 1): p. S19-s40.10.2337/dc23-S002. ElSayed NA et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care[J], 2023. 46(Suppl 1): p. S19-s40.10.2337/dc23-S002.
2.
go back to reference IDF Diabetes Atlas, in Idf diabetes atlas. 2021, International Diabetes Federation © International Diabetes Federation, 2021.: Brussels. IDF Diabetes Atlas, in Idf diabetes atlas. 2021, International Diabetes Federation © International Diabetes Federation, 2021.: Brussels.
3.
go back to reference Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet[J], 2019. 393(10191): p. 2636-2646.10.1016/s0140-6736(19)31138-9. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet[J], 2019. 393(10191): p. 2636-2646.10.1016/s0140-6736(19)31138-9.
4.
go back to reference Fielding RA et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc[J], 2011. 12(4): p. 249 – 56.10.1016/j.jamda.2011.01.003. Fielding RA et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc[J], 2011. 12(4): p. 249 – 56.10.1016/j.jamda.2011.01.003.
5.
go back to reference Cruz-Jentoft AJ et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing[J], 2019. 48(1): p. 16-31.10.1093/ageing/afy169. Cruz-Jentoft AJ et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing[J], 2019. 48(1): p. 16-31.10.1093/ageing/afy169.
6.
go back to reference Chen LK et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc[J], 2020. 21(3): p. 300–307.e2.10.1016/j.jamda.2019.12.012. Chen LK et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc[J], 2020. 21(3): p. 300–307.e2.10.1016/j.jamda.2019.12.012.
7.
go back to reference Zanker J et al. Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand. J Cachexia Sarcopenia Muscle[J], 2023. 14(1): p. 142-156.10.1002/jcsm.13115. Zanker J et al. Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand. J Cachexia Sarcopenia Muscle[J], 2023. 14(1): p. 142-156.10.1002/jcsm.13115.
8.
go back to reference Mesinovic J et al. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes[J], 2019. 12: p. 1057-1072.10.2147/dmso.s186600. Mesinovic J et al. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes[J], 2019. 12: p. 1057-1072.10.2147/dmso.s186600.
9.
go back to reference Feng L et al. Prevalence and Risk Factors of Sarcopenia in Patients With Diabetes: A Meta-analysis. J Clin Endocrinol Metab[J], 2022. 107(5): p. 1470-1483.10.1210/clinem/dgab884. Feng L et al. Prevalence and Risk Factors of Sarcopenia in Patients With Diabetes: A Meta-analysis. J Clin Endocrinol Metab[J], 2022. 107(5): p. 1470-1483.10.1210/clinem/dgab884.
10.
go back to reference Lin JA, Hou JD, Wu SY. Effect of Sarcopenia on Mortality in Type 2 Diabetes: A Long-Term Follow-Up Propensity Score-Matched Diabetes Cohort Study. J Clin Med[J], 2022. 11(15).10.3390/jcm11154424. Lin JA, Hou JD, Wu SY. Effect of Sarcopenia on Mortality in Type 2 Diabetes: A Long-Term Follow-Up Propensity Score-Matched Diabetes Cohort Study. J Clin Med[J], 2022. 11(15).10.3390/jcm11154424.
11.
go back to reference Sanz-Cánovas J et al. Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia. Int J Environ Res Public Health[J], 2022. 19(14).10.3390/ijerph19148677. Sanz-Cánovas J et al. Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia. Int J Environ Res Public Health[J], 2022. 19(14).10.3390/ijerph19148677.
12.
go back to reference Koo BK et al. Difference between old and young adults in contribution of β-cell function and sarcopenia in developing diabetes mellitus. J Diabetes Investig[J], 2016. 7(2): p. 233 – 40.10.1111/jdi.12392. Koo BK et al. Difference between old and young adults in contribution of β-cell function and sarcopenia in developing diabetes mellitus. J Diabetes Investig[J], 2016. 7(2): p. 233 – 40.10.1111/jdi.12392.
13.
go back to reference Moon. S.S. Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010. Endocr J[J], 2014. 61(1): p. 61-70.10.1507/endocrj.ej13-0244. Moon. S.S. Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010. Endocr J[J], 2014. 61(1): p. 61-70.10.1507/endocrj.ej13-0244.
14.
go back to reference Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One[J], 2010. 5(5): p. e10805.10.1371/journal.pone.0010805. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One[J], 2010. 5(5): p. e10805.10.1371/journal.pone.0010805.
15.
go back to reference Zhao Y et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol[J], 2014. 43(1): p. 61 – 8.10.1093/ije/dys203. Zhao Y et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol[J], 2014. 43(1): p. 61 – 8.10.1093/ije/dys203.
16.
go back to reference 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care[J]., 2022. 45(Suppl 1): p. S17-s38.10.2337/dc22-S002. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care[J]., 2022. 45(Suppl 1): p. S17-s38.10.2337/dc22-S002.
17.
go back to reference Wang L et al. Prevalence and Treatment of Diabetes in China, 2013–2018. Jama[J], 2021. 326(24): p. 2498-2506.10.1001/jama.2021.22208. Wang L et al. Prevalence and Treatment of Diabetes in China, 2013–2018. Jama[J], 2021. 326(24): p. 2498-2506.10.1001/jama.2021.22208.
19.
go back to reference Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med[J], 2017. 167(11): p. Itc81-itc96.10.7326/aitc201712050. Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med[J], 2017. 167(11): p. Itc81-itc96.10.7326/aitc201712050.
20.
go back to reference Cummings P. Missing data and multiple imputation. JAMA Pediatr[J], 2013. 167(7): p. 656 – 61.10.1001/jamapediatrics.2013.1329. Cummings P. Missing data and multiple imputation. JAMA Pediatr[J], 2013. 167(7): p. 656 – 61.10.1001/jamapediatrics.2013.1329.
21.
go back to reference Dodds RM et al. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants. J Cachexia Sarcopenia Muscle[J], 2020. 11(1): p. 62-68.10.1002/jcsm.12503. Dodds RM et al. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants. J Cachexia Sarcopenia Muscle[J], 2020. 11(1): p. 62-68.10.1002/jcsm.12503.
22.
go back to reference Chen Z, Ho M, Chau PH. Prevalence, Incidence, and Associated Factors of Possible Sarcopenia in Community-Dwelling Chinese Older Adults: A Population-Based Longitudinal Study. Front Med (Lausanne)[J], 2021. 8: p. 769708.10.3389/fmed.2021.769708. Chen Z, Ho M, Chau PH. Prevalence, Incidence, and Associated Factors of Possible Sarcopenia in Community-Dwelling Chinese Older Adults: A Population-Based Longitudinal Study. Front Med (Lausanne)[J], 2021. 8: p. 769708.10.3389/fmed.2021.769708.
23.
go back to reference Pérez-Sousa M et al. High Prevalence of Probable Sarcopenia in a Representative Sample From Colombia: Implications for Geriatrics in Latin America. J Am Med Dir Assoc[J], 2021. 22(4): p. 859–864.e1.10.1016/j.jamda.2020.10.021. Pérez-Sousa M et al. High Prevalence of Probable Sarcopenia in a Representative Sample From Colombia: Implications for Geriatrics in Latin America. J Am Med Dir Assoc[J], 2021. 22(4): p. 859–864.e1.10.1016/j.jamda.2020.10.021.
24.
go back to reference Wearing J et al. Prevalence of probable sarcopenia in community-dwelling older Swiss people - a cross-sectional study. BMC Geriatr[J], 2020. 20(1): p. 307.10.1186/s12877-020-01718-1. Wearing J et al. Prevalence of probable sarcopenia in community-dwelling older Swiss people - a cross-sectional study. BMC Geriatr[J], 2020. 20(1): p. 307.10.1186/s12877-020-01718-1.
25.
go back to reference Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med[J], 2017. 15(1): p. 131.10.1186/s12916-017-0901-x. Kolb H, Martin S. Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Med[J], 2017. 15(1): p. 131.10.1186/s12916-017-0901-x.
26.
go back to reference Batsis JA et al. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999–2004 National Health and Nutrition Examination Survey. Clin Nutr[J], 2016. 35(6): p. 1472-1483.10.1016/j.clnu.2016.03.028. Batsis JA et al. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999–2004 National Health and Nutrition Examination Survey. Clin Nutr[J], 2016. 35(6): p. 1472-1483.10.1016/j.clnu.2016.03.028.
27.
go back to reference Qiu S et al. Muscle strength and prediabetes progression and regression in middle-aged and older adults: a prospective cohort study. J Cachexia Sarcopenia Muscle[J], 2022. 13(2): p. 909-918.10.1002/jcsm.12905. Qiu S et al. Muscle strength and prediabetes progression and regression in middle-aged and older adults: a prospective cohort study. J Cachexia Sarcopenia Muscle[J], 2022. 13(2): p. 909-918.10.1002/jcsm.12905.
28.
go back to reference Cigarroa I et al. Association between Walking Pace and Diabetes: Findings from the Chilean National Health Survey 2016–2017. Int J Environ Res Public Health[J], 2020. 17(15).10.3390/ijerph17155341. Cigarroa I et al. Association between Walking Pace and Diabetes: Findings from the Chilean National Health Survey 2016–2017. Int J Environ Res Public Health[J], 2020. 17(15).10.3390/ijerph17155341.
29.
go back to reference Boonpor J et al. Associations between grip strength and incident type 2 diabetes: findings from the UK Biobank prospective cohort study. BMJ Open Diabetes Res Care[J], 2021. 9(1).10.1136/bmjdrc-2020-001865. Boonpor J et al. Associations between grip strength and incident type 2 diabetes: findings from the UK Biobank prospective cohort study. BMJ Open Diabetes Res Care[J], 2021. 9(1).10.1136/bmjdrc-2020-001865.
30.
go back to reference Leong DP et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet[J], 2015. 386(9990): p. 266 – 73.10.1016/s0140-6736(14)62000-6. Leong DP et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet[J], 2015. 386(9990): p. 266 – 73.10.1016/s0140-6736(14)62000-6.
31.
go back to reference Marques-Vidal P et al. Grip strength is not associated with incident type 2 diabetes mellitus in healthy adults: The CoLaus study. Diabetes Res Clin Pract[J], 2017. 132: p. 144-148.10.1016/j.diabres.2017.08.004. Marques-Vidal P et al. Grip strength is not associated with incident type 2 diabetes mellitus in healthy adults: The CoLaus study. Diabetes Res Clin Pract[J], 2017. 132: p. 144-148.10.1016/j.diabres.2017.08.004.
32.
go back to reference Remelli F et al. Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria. Aging Clin Exp Res[J], 2022. 34(1): p. 113-120.10.1007/s40520-021-01949-1. Remelli F et al. Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria. Aging Clin Exp Res[J], 2022. 34(1): p. 113-120.10.1007/s40520-021-01949-1.
33.
go back to reference Liu X et al. The Comparison of Sarcopenia Diagnostic Criteria using AWGS 2019 with the Other Five Criteria in West China. Gerontology[J], 2021. 67(4): p. 386-396.10.1159/000513247. Liu X et al. The Comparison of Sarcopenia Diagnostic Criteria using AWGS 2019 with the Other Five Criteria in West China. Gerontology[J], 2021. 67(4): p. 386-396.10.1159/000513247.
34.
go back to reference Naseeb MA, Volpe SL. Protein and exercise in the prevention of sarcopenia and aging. Nutr Res[J], 2017. 40: p. 1-20.10.1016/j.nutres.2017.01.001. Naseeb MA, Volpe SL. Protein and exercise in the prevention of sarcopenia and aging. Nutr Res[J], 2017. 40: p. 1-20.10.1016/j.nutres.2017.01.001.
35.
go back to reference Al-Ozairi E et al. Skeletal Muscle and Metabolic Health: How Do We Increase Muscle Mass and Function in People with Type 2 Diabetes? J Clin Endocrinol Metab[J], 2021. 106(2): p. 309-317.10.1210/clinem/dgaa835. Al-Ozairi E et al. Skeletal Muscle and Metabolic Health: How Do We Increase Muscle Mass and Function in People with Type 2 Diabetes? J Clin Endocrinol Metab[J], 2021. 106(2): p. 309-317.10.1210/clinem/dgaa835.
36.
go back to reference Nishikawa H et al. Metabolic Syndrome and Sarcopenia. Nutrients[J], 2021. 13(10).10.3390/nu13103519. Nishikawa H et al. Metabolic Syndrome and Sarcopenia. Nutrients[J], 2021. 13(10).10.3390/nu13103519.
37.
go back to reference DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care[J], 2009. 32 Suppl 2(Suppl 2): p. S157-63.10.2337/dc09-S302. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care[J], 2009. 32 Suppl 2(Suppl 2): p. S157-63.10.2337/dc09-S302.
38.
go back to reference Rubio-Ruiz ME et al. Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures. Int J Mol Sci[J], 2019. 20(3).10.3390/ijms20030647. Rubio-Ruiz ME et al. Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures. Int J Mol Sci[J], 2019. 20(3).10.3390/ijms20030647.
39.
go back to reference Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care[J], 2001. 24(11): p. 1917 – 22.10.2337/diacare.24.11.1917. Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care[J], 2001. 24(11): p. 1917 – 22.10.2337/diacare.24.11.1917.
40.
go back to reference Silveira Rossi JL et al. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev[J], 2022. 38(3): p. e3502.10.1002/dmrr.3502. Silveira Rossi JL et al. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev[J], 2022. 38(3): p. e3502.10.1002/dmrr.3502.
41.
go back to reference Park CH et al. Sex Difference in Cutoff and Prevalence of Sarcopenia among 300,090 Urban Korean Population: Association with Metabolic Syndrome. Medicina (Kaunas)[J], 2022. 58(10).10.3390/medicina58101361. Park CH et al. Sex Difference in Cutoff and Prevalence of Sarcopenia among 300,090 Urban Korean Population: Association with Metabolic Syndrome. Medicina (Kaunas)[J], 2022. 58(10).10.3390/medicina58101361.
42.
go back to reference [Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)]. Zhonghua Nei Ke Za Zhi[J]., 2022. 61(1): p. 12-50.10.3760/cma.j.cn112138-20211027-00751. [Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)]. Zhonghua Nei Ke Za Zhi[J]., 2022. 61(1): p. 12-50.10.3760/cma.j.cn112138-20211027-00751.
43.
go back to reference Chen R et al. Predictors of diabetes in older people in urban China. PLoS One[J], 2012. 7(11): p. e50957.10.1371/journal.pone.0050957. Chen R et al. Predictors of diabetes in older people in urban China. PLoS One[J], 2012. 7(11): p. e50957.10.1371/journal.pone.0050957.
Metadata
Title
Possible sarcopenia and risk of new-onset type 2 diabetes mellitus in older adults in China: a 7-year longitudinal cohort study
Authors
Chun Luo
Rui-yan Liu
Guang-wu Zhang
Fei Hu
Yu-hong Jin
Bing-yang Liu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04104-9

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine